Robert G. Finizio, CEO, 10% Owner at TherapeuticsMD, Inc. (TXMD), sold 50,000 shares at $5.53 ($285K) on 2014-01-21, disclosed to the SEC on 2014-01-23.
Scheduled sale ($285k) by CEO, 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.53 | 16,700 | $92K | 32.4% |
| 2 | $5.66 | 16,700 | $95K | 33.1% |
| 3 | $5.92 | 16,600 | $98K | 34.5% |
| Total | $5.70 avg | 50,000 | $285K | 100% |
| Filing → |
| TXMD | BUY | 2020-06-08 | $35K | — | Filing → |
| TXMD | BUY | 2019-10-29 | $198K | — | Filing → |
| TXMD | BUY | 2019-08-20 | $192K | — | Filing → |